The Advisory Committee on Immunization Practices (ACIP) recommended Johnson & Johnson’s Janssen COVID-19 vaccine for use in the United States among people 18 and older, and CDC has adopted those
recommendations. On February 27, the FDA authorized this vaccine for use in the United States. This is the third COVID-19 vaccine available in the U.S. Read today’s statement from CDC Director Dr. Rochelle Walensky: https://bit.ly/3b2FcUs
